Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-28

Clinical Trial Update: Autologous Bronchial Basal Cells Transplantation for Treatment of Chronic Obstructive Pulmonary Disease (COPD) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating autologous bronchial basal cell transplantation as a treatment for chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous bronchial basal cell transplantation

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1, Phase 2 | Status: UNKNOWN